AKT1 and renal cell carcinoma: As for miR-193a-3p, it was shown to target the tumor suppressor phosphatase and tensin homolog (PTEN) and mediate the PI3K/Akt pathway, thereby promoting RCC cell growth and progression (Liu L. et al., 2017; Pan Y. et al., 2018).